Published in Eur J Cancer on October 18, 2007
The Hox genes and their roles in oncogenesis. Nat Rev Cancer (2010) 3.97
PBX1 genomic pioneer function drives ERα signaling underlying progression in breast cancer. PLoS Genet (2011) 1.93
The regulation of miRNA-211 expression and its role in melanoma cell invasiveness. PLoS One (2010) 1.55
HOX proteins and leukemia. Int J Clin Exp Pathol (2008) 1.14
The RUNX1 transcription factor is expressed in serous epithelial ovarian carcinoma and contributes to cell proliferation, migration and invasion. Cell Cycle (2013) 1.08
Biochemistry of the tale transcription factors PREP, MEIS, and PBX in vertebrates. Dev Dyn (2013) 1.07
Cancer genomics identifies regulatory gene networks associated with the transition from dysplasia to advanced lung adenocarcinomas induced by c-Raf-1. PLoS One (2009) 1.04
Regulation of PBX3 expression by androgen and Let-7d in prostate cancer. Mol Cancer (2011) 1.00
HOX genes in ovarian cancer. J Ovarian Res (2011) 0.99
Prep1 and Meis1 competition for Pbx1 binding regulates protein stability and tumorigenesis. Proc Natl Acad Sci U S A (2014) 0.96
Upregulation of DLX5 promotes ovarian cancer cell proliferation by enhancing IRS-2-AKT signaling. Cancer Res (2010) 0.94
PBX3 promotes migration and invasion of colorectal cancer cells via activation of MAPK/ERK signaling pathway. World J Gastroenterol (2014) 0.92
Identification of E74-like factor 1 (ELF1) as a transcriptional regulator of the Hox cofactor MEIS1. Exp Hematol (2010) 0.89
Three-amino-acid-loop-extension homeodomain factor Meis3 regulates cell survival via PDK1. Proc Natl Acad Sci U S A (2010) 0.86
Genes regulated in metastatic osteosarcoma: evaluation by microarray analysis in four human and two mouse cell line systems. Sarcoma (2012) 0.86
Identification and analysis of conserved cis-regulatory regions of the MEIS1 gene. PLoS One (2012) 0.86
Establishment of canine hemangiosarcoma xenograft models expressing endothelial growth factors, their receptors, and angiogenesis-associated homeobox genes. BMC Cancer (2009) 0.86
To Be Specific or Not: The Critical Relationship Between Hox And TALE Proteins. Trends Genet (2016) 0.85
HOXB5 expression in oral squamous cell carcinoma. J Appl Oral Sci (2011) 0.85
Autoantibodies to tumor-associated antigens in epithelial ovarian carcinoma. J Oncol (2010) 0.84
Invasion of ovarian cancer cells is induced byPITX2-mediated activation of TGF-β and Activin-A. Mol Cancer (2015) 0.82
HOX cofactors expression and regulation in the human ovary. Reprod Biol Endocrinol (2008) 0.82
A conserved tissue-specific homeodomain-less isoform of MEIS1 is downregulated in colorectal cancer. PLoS One (2011) 0.81
Anomalous altered expressions of downstream gene-targets in TP53-miRNA pathways in head and neck cancer. Sci Rep (2014) 0.80
PBX1 is a favorable prognostic biomarker as it modulates 13-cis retinoic acid-mediated differentiation in neuroblastoma. Clin Cancer Res (2014) 0.79
TG-interacting factor 1 acts as a transcriptional repressor of sterol O-acyltransferase 2. J Lipid Res (2014) 0.78
Meis1 regulates epidermal stem cells and is required for skin tumorigenesis. PLoS One (2014) 0.78
Chromosomal binding sites of the homeotic cofactor Homothorax. Mol Genet Genomics (2008) 0.75
A Constitutive Intrinsic Inflammatory Signaling Circuit Composed of miR-196b, Meis2, PPP3CC, and p65 Drives Prostate Cancer Castration Resistance. Mol Cell (2016) 0.75
Hirschsprung disease, associated syndromes and genetics: a review. J Med Genet (2007) 4.13
The prognostic influence of tumour-infiltrating lymphocytes in cancer: a systematic review with meta-analysis. Br J Cancer (2011) 3.45
Sentinel lymph node procedure is highly accurate in squamous cell carcinoma of the vulva. J Clin Oncol (2000) 3.20
Comprehensive study of several general and type-specific primer pairs for detection of human papillomavirus DNA by PCR in paraffin-embedded cervical carcinomas. J Clin Microbiol (1996) 2.94
BRAF screening as a low-cost effective strategy for simplifying HNPCC genetic testing. J Med Genet (2004) 2.75
Preventive intervention possibilities in radiotherapy- and chemotherapy-induced oral mucositis: results of meta-analyses. J Dent Res (2006) 2.56
Cigarette smoking and human papillomavirus in patients with reported cervical cytological abnormality. BMJ (1993) 2.50
Neutral amino acid transport by membrane vesicles of Streptococcus cremoris is subject to regulation by internal pH. J Bacteriol (1987) 2.44
Elimination of uninformative variables for multivariate calibration. Anal Chem (1996) 2.30
Association of hereditary nonpolyposis colorectal cancer-related tumors displaying low microsatellite instability with MSH6 germline mutations. Am J Hum Genet (1999) 2.27
Clinical implications of malnutrition in childhood cancer patients--infections and mortality. Support Care Cancer (2014) 2.07
Evaluation of the feasibility, reliability and diagnostic value of shortened versions of the geriatric depression scale. Br J Gen Pract (1995) 1.86
Germline mutations of EXO1 gene in patients with hereditary nonpolyposis colorectal cancer (HNPCC) and atypical HNPCC forms. Gastroenterology (2001) 1.84
A potential role of macrophage activation in the treatment of cancer. Crit Rev Oncol Hematol (2002) 1.81
Clinical risk factors as predictors of postmenopausal osteoporosis in general practice. Br J Gen Pract (2001) 1.73
Transport of branched-chain amino acids in membrane vesicles of Streptococcus cremoris. J Bacteriol (1987) 1.72
Monoclonal antibodies (MT1, MT2, MB1, MB2, MB3) reactive with leukocyte subsets in paraffin-embedded tissue sections. Am J Pathol (1987) 1.71
[Summary of the Dutch College of General Practitioners' practice guideline 'Diagnosis of breast cancer']. Ned Tijdschr Geneeskd (2003) 1.71
Prognostic versus predictive value of biomarkers in oncology. Eur J Cancer (2008) 1.65
COGENT (COlorectal cancer GENeTics): an international consortium to study the role of polymorphic variation on the risk of colorectal cancer. Br J Cancer (2009) 1.62
Soft tissue leiomyosarcomas and malignant gastrointestinal stromal tumors: differences in clinical outcome and expression of multidrug resistance proteins. J Clin Oncol (2000) 1.62
Hemidesmosome formation is initiated by the beta4 integrin subunit, requires complex formation of beta4 and HD1/plectin, and involves a direct interaction between beta4 and the bullous pemphigoid antigen 180. J Cell Biol (1998) 1.58
The value of laboratory tests for the screening and recognition of alcohol abuse in primary care patients. J Fam Pract (1993) 1.57
Genes other than BRCA1 and BRCA2 involved in breast cancer susceptibility. J Med Genet (2002) 1.57
Modest effect of p53, EGFR and HER-2/neu on prognosis in epithelial ovarian cancer: a meta-analysis. Br J Cancer (2009) 1.53
Continuously infused carboplatin used as radiosensitizer in locally unresectable non-small-cell lung cancer: a multicenter phase III study. Ann Oncol (2004) 1.52
Tumour infiltration depth ≥4 mm is an indication for an elective neck dissection in pT1cN0 oral squamous cell carcinoma. Oral Oncol (2011) 1.48
CHD7 mutations and CHARGE syndrome: the clinical implications of an expanding phenotype. J Med Genet (2011) 1.45
Short-term surgical outcome and safety of risk reducing salpingo-oophorectomy in BRCA1/2 mutation carriers. Maturitas (2010) 1.43
Oestrogen replacement therapy lowers plasma levels of asymmetrical dimethylarginine in healthy postmenopausal women. Clin Sci (Lond) (2003) 1.43
Large-amplitude spin dynamics driven by a THz pulse in resonance with an electromagnon. Science (2014) 1.41
Predicting postoperative mortality after colorectal surgery: a novel clinical model. Colorectal Dis (2014) 1.41
[Surgical treatment of early-stage vulva carcinoma and the complications of the operation]. Ned Tijdschr Geneeskd (2005) 1.41
Palliative resection of the primary tumour in stage IV rectal cancer. Colorectal Dis (2012) 1.40
Apoptosis and apoptosis-associated parameters in relation to tamoxifen exposure in postmenopausal endometrium. Hum Pathol (2002) 1.39
Residual infrarenal aortic neck following endovascular and open aneurysm repair. Eur J Vasc Endovasc Surg (2012) 1.38
Intraoperative near-infrared fluorescence imaging for sentinel lymph node detection in vulvar cancer: first clinical results. Gynecol Oncol (2010) 1.38
Proximal adenomas in hereditary non-polyposis colorectal cancer are prone to rapid malignant transformation. Gut (2002) 1.38
An aCGH classifier derived from BRCA1-mutated breast cancer and benefit of high-dose platinum-based chemotherapy in HER2-negative breast cancer patients. Ann Oncol (2010) 1.35
The clinical trail of TRAIL. Eur J Cancer (2006) 1.35
Forced activation of Cdk1 via wee1 inhibition impairs homologous recombination. Oncogene (2012) 1.31
Nanoscale spin reversal by non-local angular momentum transfer following ultrafast laser excitation in ferrimagnetic GdFeCo. Nat Mater (2013) 1.31
Predictive modelling for swallowing dysfunction after primary (chemo)radiation: results of a prospective observational study. Radiother Oncol (2011) 1.31
No efficacy of annual gynaecological screening in BRCA1/2 mutation carriers; an observational follow-up study. Br J Cancer (2007) 1.30
A four-gene methylation marker panel as triage test in high-risk human papillomavirus positive patients. Int J Cancer (2012) 1.28
Expression of cyclooxygenase-2 and inducible nitric oxide synthase in human ovarian tumors and tumor-associated macrophages. Cancer Res (2001) 1.28
Telomere length in breast cancer patients before and after chemotherapy with or without stem cell transplantation. Br J Cancer (2001) 1.28
Structural alterations of transforming growth factor-beta receptor genes in human cervical carcinoma. Int J Cancer (1999) 1.27
The LIM-only protein DRAL/FHL2 binds to the cytoplasmic domain of several alpha and beta integrin chains and is recruited to adhesion complexes. J Biol Chem (2000) 1.27
Non-canonical kinase signaling by the death ligand TRAIL in cancer cells: discord in the death receptor family. Cell Death Differ (2013) 1.27
Surgery and radiotherapy in vulvar cancer. Crit Rev Oncol Hematol (2006) 1.24
Molecular imaging of breast cancer. Breast (2009) 1.22
Building a brain in the gut: development of the enteric nervous system. Clin Genet (2012) 1.21
The expression pattern of MUC1 (EMA) is related to tumour characteristics and clinical outcome of invasive ductal breast carcinoma. Histopathology (2007) 1.21
Acute and long-term toxicity following radiotherapy alone or in combination with chemotherapy for locally advanced cervical cancer. Cancer Treat Rev (2003) 1.19
Genetic factors influencing pyrimidine-antagonist chemotherapy. Pharmacogenomics J (2005) 1.18
P-glycoprotein expression and DNA topoisomerase I and II activity in benign tumors of the ovary and in malignant tumors of the ovary, before and after platinum/cyclophosphamide chemotherapy. Cancer Res (1991) 1.16
Presence of tumor-infiltrating lymphocytes is an independent prognostic factor in type I and II endometrial cancer. Gynecol Oncol (2009) 1.16
Predictive value of human papillomavirus type for histological diagnosis of women with cervical cytological abnormalities. BMJ (1995) 1.16
Non-steroidal anti-inflammatory drugs to potentiate chemotherapy effects: from lab to clinic. Crit Rev Oncol Hematol (2006) 1.16
Amino acid sequence of a conserved neutralizing epitope of murine coronaviruses. J Virol (1989) 1.15
The ErbB signalling pathway: protein expression and prognostic value in epithelial ovarian cancer. Br J Cancer (2008) 1.15
The distribution of drug-efflux pumps, P-gp, BCRP, MRP1 and MRP2, in the normal blood-testis barrier and in primary testicular tumours. Eur J Cancer (2004) 1.14
Tamoxifen treatment and gynecologic side effects: a review. Obstet Gynecol (2001) 1.14
Clinical value of routine serum squamous cell carcinoma antigen in follow-up of patients with early-stage cervical cancer. J Clin Oncol (2001) 1.14
Soluble TRAIL concentrations are raised in patients with systemic lupus erythematosus. Ann Rheum Dis (2004) 1.13
Molecular subtypes of breast cancer and amplification of topoisomerase II alpha: predictive role in dose intensive adjuvant chemotherapy. Br J Cancer (2006) 1.12
Life expectancy in differentiated thyroid cancer: a novel approach to survival analysis. Endocr Relat Cancer (2005) 1.12
A role for MLH3 in hereditary nonpolyposis colorectal cancer. Nat Genet (2001) 1.11
The importance of the groin node status for the survival of T1 and T2 vulval carcinoma patients. Gynecol Oncol (1995) 1.11
TRAIL receptor targeting therapies for non-small cell lung cancer: current status and perspectives. Drug Resist Updat (2009) 1.11